Alison C Roxby

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. pmc Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir
    Alison C Roxby
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    AIDS Res Hum Retroviruses 29:94-8. 2013
  2. pmc Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2
    Alison C Roxby
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 7:e38622. 2012
  3. pmc Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women
    Alison C Roxby
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 6:e19947. 2011
  4. pmc Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial
    Alison L Drake
    Department of Global Health, University of Washington, Seattle 98195 7236, USA
    J Infect Dis 205:366-75. 2012
  5. pmc Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial
    Alison L Drake
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 7:e34635. 2012

Collaborators

Detail Information

Publications5

  1. pmc Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir
    Alison C Roxby
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    AIDS Res Hum Retroviruses 29:94-8. 2013
    ..Further study is needed to understand the mechanism of HIV-1 RNA reduction following herpes suppression among those coinfected with HIV-1 and HSV-2...
  2. pmc Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2
    Alison C Roxby
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 7:e38622. 2012
    ..Herpes simplex virus type 2 (HSV-2) suppression has been shown to reduce HIV-1 disease progression in non-pregnant women and men, but effects on pregnant and postpartum women have not been described...
  3. pmc Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women
    Alison C Roxby
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 6:e19947. 2011
    ..The impact of HSV-2 on clinical outcomes among HIV-1 infected pregnant women is unclear...
  4. pmc Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial
    Alison L Drake
    Department of Global Health, University of Washington, Seattle 98195 7236, USA
    J Infect Dis 205:366-75. 2012
    ..The effect of herpes simplex virus type 2 (HSV-2) suppression on human immunodeficiency virus type 1 (HIV-1) RNA in the context of prevention of mother-to-child transmission (PMTCT) interventions is unknown...
  5. pmc Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial
    Alison L Drake
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 7:e34635. 2012
    ..However, the safety profile of prolonged infant and maternal exposure to acyclovir in the context of antiretrovirals (ARVs) for prevention of mother-to-child HIV-1 transmission (PMTCT) has not been described...